Follow-The-Filings

Holders · period archive

AGMB · Agomab Therapeutics NV

Q2 2026 13F holders among managers we track latest ownership dossier

Ticker
AGMB
Type
Equity
Class
ADS
Total reported value ($000, long equity)
Manager Report date Value Shares